この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Sergio L.に依頼
Spain
Biotech R&D Consultant | Program Leader | 10+ Years | Biologics, Gene Therapy | Inventor
プロフィール概要
専門分野
サービス
Writing
Clinical Trial Documentation,
Medical Writing,
Non-Medical Regulatory Writing,
Technical Writing,
Business & Legal Writing,
Copywriting,
Creative Writing,
Newswriting,
Audio Transcription,
Translation
Research
User Research,
Meta-Research,
Feasibility Study,
Technology Scouting,
Fact Checking,
Gap Analysis,
Gray Literature Search,
Scientific and Technical Research,
Systematic Literature Review,
Secondary Data Collection
Consulting
Business Strategy Consulting,
Scientific and Technical Consulting,
Regulatory Consulting
職務経験
Life Science Consultant
Forward R&D Consulting
3月 2026 - 現在
Almirall (Spain)
3月 2021 - 現在 ![]()
Program Leader / Principal Investigator
Almirall (Spain)
3月 2021 - 2月 2026 ![]()
Group Leader/ Principal Investigator
Almirall
2月 2021 - 2月 2026
Scientific Advisor
Breast International Group
9月 2020 - 2月 2021 ![]()
Scientific Advisor
Breast International Group
9月 2020 - 2月 2021
Translational Scientist
Genmab
2月 2019 - 1月 2020
Scientist
Genmab (Netherlands)
2月 2019 - 1月 2020 ![]()
Postdoctoral scientist (in vivo)
Janssen (Belgium)
9月 2016 - 11月 2018 ![]()
Postdoctroral Researcher
Janssen Pharmaceutica NV
9月 2016 - 11月 2018
Postdoc
The Wistar Institute Cancer Center
9月 2013 - 8月 2016 ![]()
Postdoctroral Researcher
The Wistar Institute
9月 2013 - 7月 2016
Consultant
PBG Healthcare Consulting (University of Pennsylvania)
9月 2015 - 4月 2016
Tech Transfer Fellow
Business Development Office (The Wistar Institute)
6月 2015 - 12月 2015
Post Doctoral Visiting Fellow
National Institutes of Health (NIH, Bethesda)
9月 2012 - 9月 2013
Visiting Fellow
US National Institutes of Health
9月 2012 - 9月 2013 ![]()
学歴
PhD
University of Helsinki
7月 2006 - 7月 2012
PhD
University of Helsinki
7月 2006 - 7月 2012 ![]()
Master of Pharmacy (School of Pharmacy (Facultat de Farmacia))
Universitat de Barcelona
9月 1999 - 9月 2005 ![]()
Master in Pharmacy
University of Barcelona
9月 1999 - 7月 2005
認定資格
出版物
JOURNAL ARTICLE
Sergio Lavilla-Alonso, Jérôme Mastio, Thomas Condamine, George Dominguez, Andrew V. Kossenkov, Laxminarasimha Donthireddy, Filippo Veglia, Cindy Lin, Fang Wang, Shuyu Fu, et al. (2019). Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs . Journal of Experimental Medicine.
Sergio Lavilla-Alonso, Cigdem Atay, Taekyoung Kwak, Laxminarasimha Donthireddy, Allison Richards, Valerie Moberg, Shari Pilon-Thomas, Michael Schell, Jane L. Messina, Vito W. Rebecca, et al. (2019). BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells . Clinical Cancer Research.
Sergio Lavilla-Alonso, Vinit Kumar, Laxminarasimha Donthireddy, Douglas Marvel, Thomas Condamine, Fang Wang, Ayumi Hashimoto, Prashanthi Vonteddu, Reeti Behera, Marlee A. Goins, et al. (2017). Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors . Cancer Cell.
Sergio Lavilla-Alonso, Shailaja Raj, Marilyn M. Bui, Gregory Springett, Anthony Conley, Xiuhua Zhao, Dungsa Chen, Randy Haysek, Ricardo Gonzalez, G. Douglas Letson, et al. (2015). Long-Term Clinical Responses of Neoadjuvant Dendritic Cell Infusions and Radiation in Soft Tissue Sarcoma . Sarcoma.
Sergio Lavilla-Alonso, Sungjune Kim, Rupal Ramakrishnan, Prakash Chinnaiyan, Nikhil Rao, Erin Fowler, John Heine, Dmitry I. Gabrilovich (2014). Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice . Cancer Immunology, Immunotherapy.
Sergio Lavilla-Alonso, Erkko Ylösmäki, Sari Jäämaa, Markus Vähä-Koskela, Taija af Hällström, Akseli Hemminki, Johanna Arola, Heikki Mäkisalo, Kalle Saksela (2013). MicroRNA-Mediated Suppression of Oncolytic Adenovirus Replication in Human Liver . PLoS ONE.
S Lavilla-Alonso, M M T Bauer, U Abo-Ramadan, A Ristimäki, J Halavaara, R A Desmond, D Wang, S Escutenaire, L Ahtiainen, K Saksela, et al. (2012). Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development . Cancer Gene Therapy.
Sergio Lavilla-Alonso, Usama Abo-Ramadan, Juha Halavaara, Sophie Escutenaire, Turgut Tatlisumak, Kalle Saksela, Anna Kanerva, Akseli Hemminki, Sari Pesonen (2011). Optimized Mouse Model for the Imaging of Tumor Metastasis upon Experimental Therapy . PLoS ONE.
O Hemminki, G Bauerschmitz, S Hemmi, S Lavilla-Alonso, I Diaconu, K Guse, A Koski, R A Desmond, M Lappalainen, A Kanerva, et al. (2011). Oncolytic adenovirus based on serotype 3 . Cancer Gene Therapy.
Sergio Lavilla-Alonso, Gerd Bauerschmitz, Usama Abo-Ramadan, Juha Halavaara, Sophie Escutenaire, Iulia Diaconu, Turgut Tatlisumak, Anna Kanerva, Akseli Hemminki, Sari Pesonen (2010). Adenoviruses with an αvβ integrin targeting moiety in the fiber shaft or the HI-loop increase tumor specificity without compromising antitumor efficacy in magnetic resonance imaging of colorectal cancer metastases . Journal of Translational Medicine.
Sergio Lavilla-Alonso, Neus Bayo-Puxan, Marta Gimenez-Alejandre, Alena Gros, Manel Cascallo, Akseli Hemminki, Ramon Alemany (2009). Replacement of Adenovirus Type 5 Fiber Shaft Heparan Sulfate Proteoglycan-Binding Domain with RGD for Improved Tumor Infectivity and Targeting . Human Gene Therapy.
Sergio Lavilla-Alonso, Anna Kanerva, Mari Raki, Lotta Kangasniemi, Gerd J. Bauerschmitz, Koichi Takayama, Ari Ristimäki, Renee A. Desmond, Akseli Hemminki (2008). Systemic Therapy for Cervical Cancer with Potentially Regulatable Oncolytic Adenoviruses . PLoS ONE.